Metabolite footprinting of Plasmodium falciparum following exposure to Garcinia mangostana Linn. crude extract

Experimental Parasitology

Volumn 145, Issue 1, 2014, Pages 80-86

  Chaijaroenkul, Wanna ^a   Mubaraki, Murad A ^b,c   Ward, Stephen A ^b   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Garcinia mangostana Linn.; Metabolic footprinting; Metabolic pathways; Plasmodium falciparum

Indexed keywords

9 HYDROXYCARBAXATHONE; ALPHA MANGOSTIN; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; GARCINIA MANGOSTANA EXTRACT; GARTANIN; MANGOSTIN; MEFLOQUINE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; ARTEMISININ DERIVATIVE; GLUCOSE; XANTHONE DERIVATIVE; 9 HYDROXYCALABAXANTHONE; BETA MANGOSTIN;

ANTIMALARIAL ACTIVITY; ARTICLE; CITRIC ACID CYCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG EXPOSURE; DRUG STRUCTURE; GLUCOSE METABOLISM; GROWTH INHIBITION; IC 50; METABOLITE; NONHUMAN; PHYTOCHEMISTRY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TROPHOZOITE; CHEMISTRY; DRUG EFFECTS; GARCINIA MANGOSTANA; IC50; ISOLATION AND PURIFICATION; METABOLISM; MULTIDRUG RESISTANCE; CULTURE MEDIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION REDUCTION STATE; SIGNAL TRANSDUCTION;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE, MULTIPLE; GARCINIA MANGOSTANA; GLUCOSE; INHIBITORY CONCENTRATION 50; MEFLOQUINE; METABOLIC NETWORKS AND PATHWAYS; PLANT EXTRACTS; PLASMODIUM FALCIPARUM; XANTHONES;

EID: 84908349766     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2014.07.013     Document Type: Article

References (42)

1. Akao Y., Nakagawa Y., Iinuma M., Nozawa Y. Anti-cancer effects of xanthones from pericarps of mangosteen. Int. J. Mol. Sci. 2008, 9:355-370.
2. Bennett T.N., Paguio M., Gligorijevic B., Seudieu C., Kosar A.D., Davidson E., Roepe P.D. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob. Agents Chemother. 2004, 48:1807-1810.
3. Biagini G.A., Fisher N., Shone A.E., Mubaraki M.A., Srivastava A., Hill A., Antoine T., Warman A.J., Davies J., Pidathala C., Amewu R.K., Leung S.C., Sharma R., Gibbons P., Hong D.W., Pacorel B., Lawrenson A.S., Charoensutthivarakul S., Taylor L., Berger O., Mbekeani A., Stocks P.A., Nixon G.L., Chadwick J., Hemingway J., Delves M.J., Sinden R.E., Zeeman A.M., Kocken C.H., Berry N.G., O'Neill P.M., Ward S.A. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:8298-8303.
4. Buchholz A., Hurlebaus J., Wandrey C., Takors R. Metabolomics: quantification of intracellular metabolite dynamics. Biomol. Eng. 2002, 19:5-15.
5. Bumrungpert A., Kalpravidh R.W., Chuang C.C., Overman A., Martinez K., Kennedy A., McIntosh M. Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. J. Nutr. 2010, 140:842-847.
6. Carrara V.I., Zwang J., Ashley E.A., Price R.N., Stepniewska K., Barends M., Brockman A., Anderson T., McGready R., Phaiphun L., Proux S., van Vugt M., Hutagalung R., Lwin K.M., Phyo A.P., Preechapornkul P., Imwong M., Pukrittayakamee S., Singhasivanon P., White N.J., Nosten F. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13years of continuous deployment. PLoS One 2009, 4:e4551.
7. Chen L.G., Yang L.L., Wang C.C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 2008, 46:688-693.
8. Chomnawang M.T., Surassmo S., Wongsariya K., Bunyapraphatsara N. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia 2009, 80:102-104.
9. Devi Sampath P., Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J. Biochem. Mol. Toxicol. 2007, 21:336-339.
10. Elford B.C., Cowman G.M., Ferguson D.J.P. Parasite regulated membrane transport processes and metabolic control in malaria-infected erythrocytes. Biochem. J. 1995, 308:361-374.
11. Han A.R., Kim J.A., Lantvit D.D., Kardono L.B., Riswan S., Chai H., Carcache de Blanco E.J., Farnsworth N.R., Swanson S.M., Kinghorn A.D. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J. Nat. Prod. 2009, 72:2028-2031.
12. Hay A.E., Helesbeux J.J., Duval O., Labaied M., Grellier P., Richomme P. Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii. Life Sci. 2004, 75:3077-3085.
13. Ho C.K., Huang Y.L., Chen C.C. Garcinone E, a xanthone derivative, has potent cytotoxic effect against hepatocellular carcinoma cell lines. Planta Med. 2002, 68:975-979.
14. Kaderbhai N.N., Broadhurst D.I., Ellis D.I., Goodacre R., Kell D.B. Functional genomics via metabolic footprinting: monitoring metabolite secretion by Escherichia coli tryptophan metabolism mutants using FT-IR and direct injection electrospray mass spectrometry. Comp. Funct. Genomics 2003, 4:376-391.
15. Kaomongkolgit R., Jamdee K., Chaisomboon N. Antifungal activity of alpha-mangostin against Candida albicans. J. Oral Sci. 2009, 51:401-406.
16. Kell D.B., Brown M., Davey H.M., Dunn W.B., Spasic I., Oliver S.G. Metabolic footprinting and systems biology: the medium is the message. Nat. Rev. Microbiol. 2005, 3:557-565.
17. Lannang A.M., Komguem J., Ngninzeko F.N., Tangmouo J.G., Lontsi D., Ajaz A., Choudhary M.I., Ranjit R., Devkota K.P., Sondengam B.L. Bangangxanthone A and B, two xanthones from the stem bark of Garcinia polyantha Oliv. Phytochemistry 2005, 66:2351-2355.
18. Lannang A.M., Louh G.N., Lontsi D., Specht S., Sarite S.R., Florke U., Hussain H., Hoerauf A., Krohn K. Antimalarial compounds from the root bark of Garcinia polyantha Olv. J. Antibiot. (Tokyo) 2008, 61:518-523.
19. Likhitwitayawuid K., Phadungcharoen T., Krungkrai J. Antimalarial xanthones from Garcinia cowa. Planta Med. 1998, 64:70-72.
20. Lim P., Alker A.P., Khim N., Shah N.K., Incardona S., Doung S., Yi P., Bouth D.M., Bouchier C., Puijalon O.M., Meshnick S.R., Wongsrichanalai C., Fandeur T., Le Bras J., Ringwald P., Ariey F. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 2009, 8:11.
21. Mahabusarakam W., Kuaha K., Wilairat P., Taylor W.C. Prenylated xanthones as potential antiplasmodial substances. Planta Med. 2006, 72:912-916.
22. Mapelli V., Olsson L., Nielsen J. Metabolic footprinting in microbiology: methods and applications in functional genomics and biotechnology. Trends Biotechnol. 2008, 26:490-497.
23. MacRae J.I., Dixon M.W., Dearnley M.K., Chua H.H., Chambers J.M., Kenny S., Bottova I., Tilley L., McConville M.J. Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum. BMC Biol. 2013, 11:67.
24. Moongkarndi P., Kosem N., Kaslungka S., Luanratana O., Pongpan N., Neungton N. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J. Ethnopharmacol. 2004, 90:161-166.
25. Muller S. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol. Microbiol. 2004, 53:1291-1305.
26. Na-Bangchang K., Ruengweerayut R., Mahamad P., Ruengweerayut K., Chaijaroenkul W. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Malar. J. 2010, 9:273.
27. Nabandith V., Suzui M., Morioka T., Kaneshiro T., Kinjo T., Matsumoto K., Akao Y., Iinuma M., Yoshimi N. Inhibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac. J. Cancer Prev. 2004, 5:433-438.
28. Nguyen L.H., Venkatraman G., Sim K.Y., Harrison L.J. Xanthones and benzophenones from Garcinia griffithii and Garcinia mangostana. Phytochemistry 2005, 66:1718-1723.
29. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 2008, 359:2619-2620.
30. Rasoanaivo P., Deharo E., Urverg S.R., Frappier F. Guidelines for the nonclinical evaluation of the efficacy of traditional antimalarials. Traditional Medicinal Plants And Malaria 2004, CRC Press, Boca Raton. M. Willcox, P. Rasoanaivo, G. Bodeker (Eds.).
31. Riscoe M., Kelly J.X., Winter R. Xanthones as antimalarial agents: discovery, mode of action, and optimization. Curr. Med. Chem. 2005, 12:2539-2549.
32. Rogers W.O., Sem R., Tero T., Chim P., Lim P., Muth S., Socheat D., Ariey F., Wongsrichanalai C. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 2009, 8:10.
33. Sakagami Y., Iinuma M., Piyasena K.G., Dharmaratne H.R. Antibacterial activity of alpha-mangostin against vancomycin resistant enterococci (VRE) and synergism with antibiotics. Phytomedicine 2005, 12:203-208.
34. Shan T., Ma Q., Guo K., Liu J., Li W., Wang F., Wu E. Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Curr. Mol. Med. 2011, 11:666-677.
35. Sherman I.W. Amino acid metabolism and protein synthesis in malarial parasites. Bull. World Health Organ. 1977, 55:265-276.
36. Smilkstein M., Sriwilaijaroen N., Kelly J.X., Wilairat P., Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 2004, 48:1803-1806.
37. Suksamrarn S., Komutiban O., Ratananukul P., Chimnoi N., Lartpornmatulee N., Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem. Pharm. Bull. (Tokyo) 2006, 54:301-305.
38. Thiengsusuk A., Chaijaroenkul W., Na-Bangchang K. Antimalarial activities of medicinal plants and herbal formulations used in Thai traditional medicine. Parasitol. Res. 2013, 112:1475-1481.
39. Tona L., Cimanga R.K., Mesia K., Musuamba C.T., De Bruyne T., Apers S., Hernans N., Van Miert S., Pieters L., Totte J., Vlietinck A.J. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J. Ethnopharmacol. 2004, 93:27-32.
40. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193:673-675.
41. Vijaykadga S., Rojanawatsirivej C., Cholpol S., Phoungmanee D., Nakavej A., Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop. Med. Int. Health 2006, 11:211-219.
42. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2002, 2:209-218.